Medtronic’s controversial bone growth product Infuse has been hammered by quarter after quarter of declining sales.Currently, Yale reviewers are conducting an independent review of the data related to Infuse. The review’s conclusions are eagerly awaited by Medtronic CEO Omar Ishrak who hopes that Infuse will be vindicated once and for all therebysilencing those who have [...]

Medtronic (NYSE:MDT) announced Monday that the U.S. Food and Drug Administration approved a new high-voltage connector system for use with its implantable cardioverter and cardiac resynchronization therapy defibrillatorsthat correct abnormal heart rhythm.The new DF4 connector system boasts fewer connection points between the device and the defibrillation leads. It has a single set-screw to connect the [...]

Medtronic(NYSE:MDT) announced Friday that it will begin to sell minimally invasive cardiac surgery instruments as part of a distribution agreement with a design company based in Florida.Miami Instruments designs surgical instruments for minimally invasive cardiac procedures, and Medtronic said that it is launching two of Miami Instruments’ products in the U.S. Terms of the distribution [...]

Medtronic (NYSE: MDT), the maker of new innovative medical devices, announced Tuesday the European approval and international launch of its new stent graft system.The Endurant II AAA stent graft system is designed to provide greater options to physicians in repairing abdominal aortic aneurysms (AAA).An abdominal aorticaneurysm occurswhen the large blood vessel that supplies blood [...]

SCROLL BELOW FOR UPDATE:At the JP Morgan Healthcare Conference in San Francisco on Monday, Medtronic CEO Omar Ishrak once again laid out his three-pronged effort to rejuvenate medical device maker Medtronic (NYSE:MDT): improving execution, optimizing medical device innovation and quickly expanding its global footprint.Of the three, the biggest challenge will be in optimizing innovation because [...]

Finding and maintaining an edge in medical device innovation is the holy grail of companies like Medtronic (NYSE:MDT).In late November, Medtronic CEO Omar Ishrak had this tantalizing tweet about that topic:Returned from exciting trip to#Israel. Amazing entrepreneurial spirit and energy. Could be next innovation incubator for#Medtronic.var page_count = “off”; [...]

Medtronic(NYSE:MDT), the maker of new innovative medical devices, announced the U.S. launch of a new remote glucose monitor that allows caregivers to be aware of glucose levels of the patient in another room.Describing mySentry as a first-of-its-kind monitor, Medtronic said that it would allow parents and other caregivers to know in real time glucose levels [...]

Transcatheter aortic valve implantation has been hailed as an exciting technology able to treat acute cardiac stenosis in patients who cannot undergo open-heart surgery.But now the Mayo Clinic has found that the procedure requires a lot of practice. And that raises the question of how widely the nascent technology will be adopted in the U.S. [...]

The U.S. attorney in Minneapolis settled a kickback case with device maker Medtronic yesterday, with the company agreeing to pay $23.5 million without admitting it paid doctors $1,000 to $2,000 for choosing its brand of defibrillator. What is so galling about this and other cases like it is that the physicians were being asked to [...]

Medtronic (NYSE:MDT) will shell out $23.5 million to settle accusations that it paid kickbacks to doctors who implanted its pacemakers and cardiac defibrillators, the company announced Monday.Medtronic was accused of soliciting physicians to participate in post-market studies and device registries, offering them between $1,000 and $2,000 per patient for using Medtronic’s device, according to the [...]